Predictors of defaulting from treatment among patients with tuberculosis

Mohammad Abdulrazaq (Baghdad, Iraq), Mohammad Abdulrazaq, Layth Salihi, Abdulla Alfarttoosi

Source: International Congress 2015 – Management of TB: a patient focus
Session: Management of TB: a patient focus
Session type: Thematic Poster Session
Number: 2733
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mohammad Abdulrazaq (Baghdad, Iraq), Mohammad Abdulrazaq, Layth Salihi, Abdulla Alfarttoosi. Predictors of defaulting from treatment among patients with tuberculosis. Eur Respir J 2015; 46: Suppl. 59, 2733

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of mandatory treatment for tuberculosis - An observational registry study
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013

Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016



Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Failure predictors when treating MDR-TB
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016



Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015


Could side effects of MDR-TB treatment change the outcome of the disease?
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


The death analysis of HIV-infected patients in the antituberculous hospital
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015


Healing predictors when treating MDR-TB
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Treatment outcomes of new TB cases among children in Russia
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015